Screener
Charles River Laboratories CRL Impairment of intangible assets
Discontinued — last reported Q4 '25
Impairment of intangible assets at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.
The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 9:21 AM EST
- Fiscal year
- FY2025
- Accession
- 0001100682-26-000022
| Line item | Fiscal Year / 2025 | Fiscal Year / 2024 | Fiscal Year / 2023 |
|---|---|---|---|
| Cost of products sold (excluding amortization of intangible assets) | 377,347 | 372,387 | 330,870 |
| Selling, general and administrative | 743,073 | 751,003 | 747,855 |
| Amortization of intangible assets | 179,066 | 138,471 | 137,440 |
| Intangible asset impairment | 210,974 | — | — |
| Goodwill impairment | 165,000 | 215,000 | — |
| Operating income | 25,162 | 227,347 | 617,261 |
| Other income (expense) | |||
| Interest income | 4,940 | 8,575 | 5,196 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Charles River Laboratories's impairment of intangible assets?
- Charles River Laboratories (CRL) reported impairment of intangible assets of $52.74M in Q4 2025.
- What does impairment of intangible assets mean?
- This metric represents the reduction in the carrying value of finite-lived intangible assets when their fair value falls below their book value. It indicates that the expected future economic benefits from assets like patents, trademarks, or customer lists have declined. Frequent impairments may suggest poor historical acquisition decisions or rapid technological obsolescence.
Ask your AI about Charles River Laboratories's impairment of intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude